Table of Contents
ISRN Hematology
Volume 2014, Article ID 895721, 11 pages
http://dx.doi.org/10.1155/2014/895721
Review Article

Oral and Dental Considerations in Pediatric Leukemic Patient

1Department of Pedodontics and Preventive Dentistry, Malla Reddy Institute of Dental Sciences, Hyderabad, Andhra Pradesh, India
2NTR University of Health Sciences, Vijayawada, Andhra Pradesh, India
3Department of Pedodontics and Preventive Dentistry, Mally Reddy Women’s Dental College, Hyderabad, Andhra Pradesh, India

Received 7 December 2013; Accepted 17 January 2014; Published 4 March 2014

Academic Editors: C. Gruellich and E. M. Rego

Copyright © 2014 Chiyadu Padmini and K. Yellamma Bai. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Smith and L. A. G. Ries, “Childhood cancer: incidence, survival, and mortality,” in Principles and Practice of Pediatric Oncology, P. A. Pizzo and D. G. Poplack, Eds., pp. 1–12, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 2002. View at Google Scholar
  2. F. M. Balis, J. S. Holcenberg, and S. M. Blaney, “General principles of chemotherapy,” in Principles and Practice of Pediatric Oncology, P. A. Pizzo and D. G. Poplack, Eds., pp. 237–308, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 2002. View at Google Scholar
  3. J. F. Margolin, C. P. Steuber, and D. G. Poplack, “Acute lymphoblastic leukemia,” in Principles and Practice of Pediatric Oncology, P. A. Pizzo and D. G. Poplack, Eds., pp. 489–544, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 2002. View at Google Scholar
  4. C. L. Sawyers, C. T. Denny, and O. N. Witte, “Leukemia and the disruption of normal hematopoiesis,” Cell, vol. 64, no. 2, pp. 337–350, 1991. View at Google Scholar · View at Scopus
  5. S. Farber, L. K. Diamond, R. D. Mercer, R. F. Sylvester, and J. A. Wolff, “Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin),” The New England Journal of Medicine, vol. 238, no. 23, pp. 787–793, 1948. View at Publisher · View at Google Scholar
  6. S. L. George, R. J. A. Aur, A. M. Mauer, and J. V. Simone, “A reappraisal of the results of stopping therapy in childhood leukemia,” The New England Journal of Medicine, vol. 300, no. 6, pp. 269–273, 1979. View at Google Scholar · View at Scopus
  7. G.-L. Hou, J.-S. Huang, and C.-C. Tsai, “Analysis of oral manifestations of leukemia: a retrospective study,” Oral Diseases, vol. 3, no. 1, pp. 31–38, 1997. View at Google Scholar · View at Scopus
  8. E. Barbería, C. Hernandez, V. Miralles, and M. Maroto, “Paediatric patients receiving oncology therapy: review of the literature and oral management guidelines,” European Journal of Paediatric Dentistry, vol. 9, no. 4, pp. 188–194, 2008. View at Google Scholar · View at Scopus
  9. National Cancer Institute, PDQ Oral Complications of Chemotherapy and Head/Neck Radiation, National Cancer Institute, Bethesda, Md, USA, 2013, http://cancer.gov/cancertopics/pdq/supportivecare/oralcomplications/HealthProfessional.
  10. World Health Organization, Handbook for Reporting Results of Cancer Treatment, World Health Organization, Geneva, Switzerland, 1979.
  11. Common Terminology Criteria for Adverse Events, version 4.0. U.S. Department of Health and Human Services, National Institutes of Health, National 22. Cancer Institute. Cancer Therapy Evaluation Program.
  12. J. Eilers, A. M. Berger, and M. C. Petersen, “Development, testing, and application of the oral assessment guide,” Oncology Nursing Forum, vol. 15, no. 3, pp. 325–330, 1988. View at Google Scholar · View at Scopus
  13. D. M. Keefe, M. M. Schubert, L. S. Elting et al., “Updated clinical practice guidelines for the prevention and treatment of mucositis,” Cancer, vol. 109, no. 5, pp. 820–831, 2007. View at Publisher · View at Google Scholar
  14. B. C. López, “Dental treatment considerations in the chemotherapy patient,” Journal of Clinical and Experimental Dentistry, vol. 3, no. 1, pp. e31–e42, 2011. View at Google Scholar
  15. J. W. Little, D. A. Falace, C. S. Miller, and N. L. Rhodus, Dental Management of the Medically Compromised Patient, Mosby, St. Louis, Mo, USA, 7th edition, 2008.
  16. American Academy of Pediatric Dentistry, “Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation,” Pediatric Dentistry, vol. 34, no. 6, p. 280, 2012. View at Google Scholar
  17. L. M. Baddour, M. A. Bettmann, A. F. Bolger et al., “Nonvalvular cardiovascular device-related infections,” Circulation, vol. 108, no. 16, pp. 2015–2031, 2003. View at Google Scholar
  18. W. Wilson, K. A. Taubert, M. Gewitz et al., “Prevention of infective endocarditis: guidelines from the American heart association,” Circulation, vol. 116, no. 15, pp. 1736–1754, 2007. View at Google Scholar
  19. M. M. Schubert, J. B. Epstein, and D. E. Peterson, “Oral complications of cancer therapy,” in Pharmacology and Therapeutics for Dentistry, J. A. Yagiela, F. J. Dowd, and E. A. Neidle, Eds., pp. 797–813, Mosby-Year Book, St. Louis, Mo, USA, 5th edition, 2004. View at Google Scholar
  20. NCI/NIH Resources Page, NCI Cancer Information web site.
  21. A. Ransier, J. B. Epstein, R. Lunn, and J. Spinelli, “A combined analysis of a toothbrush, foam brush, and a chlorhexidine-soaked foam brush in maintaining oral hygiene,” Cancer Nursing, vol. 18, no. 5, pp. 393–396, 1995. View at Google Scholar · View at Scopus
  22. K. Lawson, “Oral-dental concerns of the pediatric oncology patient,” Issues in Comprehensive Pediatric Nursing, vol. 12, no. 2-3, pp. 199–206, 1989. View at Google Scholar · View at Scopus
  23. S. E. Semba, B. L. Mealey, and W. W. Hallmon, “Dentistry and the cancer patient: part 2—oral health management of the chemotherapy patient,” Compendium, vol. 15, no. 11, pp. 1378–1387, 1994. View at Google Scholar · View at Scopus
  24. P. Gjermo, “Chlorhexidine and related compounds,” Journal of Dental Research, vol. 68, pp. 1602–1608, 1989. View at Google Scholar · View at Scopus
  25. C. A. Migliorati, J. Casiglia, J. Epstein, P. L. Jacobsem, M. A. Siegel, and S. B. Woo, “Managing the care of patients with bisphosphonate-associated osteonecrosis: an American academy of oral medicine position paper,” Journal of the American Dental Association, vol. 136, no. 12, pp. 1658–1668, 2005, Erratum in Journal of the American Dental Association, vol. 137, no. 1, p. 26, 2006. View at Google Scholar · View at Scopus
  26. S. L. Ruggiero, J. Fantasia, and E. Carlson, “Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 102, no. 4, pp. 433–441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. Schubert, K. M. Sullivan, and E. L. Truelove, “Head and neck complications of bone marrow transplantation,” in Head and Neck Management of the Cancer Patient, D. E. Peterson, E. G. Elias, and S. T. Sonis, Eds., pp. 401–427, Martinus Nijhoff, Boston, Mass, USA, 1986. View at Google Scholar
  28. M. Hudspeth and H. Symons, “Hematology,” in The Harriet Lane Handbook, V. L. Gunn and C. Nechyba, Eds., pp. 283–306, Mosby, Philadelphia, Pa, USA, 16th edition, 2002. View at Google Scholar
  29. G. Dahllöf, A. Jönsson, M. Ulmner, and J. Huggare, “Orthodontic treatment in long-term survivors after pediatric bone marrow transplantation,” The American Journal of Orthodontics and Dentofacial Orthopedics, vol. 120, no. 5, pp. 459–465, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. M. C. Williams and M. V. Martin, “A longitudinal study of the effects on the oral mucosa of treatment for acute childhood leukaemia,” International Journal of Paediatric Dentistry, vol. 2, no. 2, pp. 73–79, 1992. View at Google Scholar · View at Scopus
  31. G. G. Duncan, J. B. Epstein, D. Tu et al., “Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis,” Head and Neck, vol. 27, no. 5, pp. 421–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Barasch and D. E. Peterson, “Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions,” Oral Oncology, vol. 39, no. 2, pp. 91–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. R. V. Lalla, S. T. Sonis, and D. E. Peterson, “Management of oral mucositis in patients who have cancer,” Dental Clinics of North America, vol. 52, no. 1, pp. 61–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. V. Lalla and D. E. Peterson, “Oral mucositis,” Dental Clinics of North America, vol. 49, no. 1, pp. 167–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. J. B. Epstein, M. Gorsky, A. Guglietta, N. Le, and S. T. Sonis, “The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy,” Cancer, vol. 89, no. 11, pp. 2258–2265, 2000. View at Publisher · View at Google Scholar
  36. L. S. Elting, C. D. Cooksley, M. S. Chambers, and A. S. Garden, “Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 4, pp. 1110–1120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Trotti, L. A. Bellm, J. B. Epstein et al., “Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review,” Radiotherapy and Oncology, vol. 66, no. 3, pp. 253–262, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. da Fonseca, “Dental care of the pediatric cancer patient,” Pediatric Dentistry, vol. 26, no. 1, pp. 53–57, 2004. View at Google Scholar · View at Scopus
  39. M. M. Miller, V. David, and T. M. Hagemann, “Prevention and treatment of oral mucositis in children with cancer,” Journal of Pediatric Pharmacology and Therapeutics, vol. 17, no. 4, pp. 340–350, 2012. View at Publisher · View at Google Scholar
  40. K. K. Cheng, A. Molassiotis, A. M. Chang, W. C. Wai, and S. S. Cheung, “Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients,” European Journal of Cancer, vol. 37, no. 16, pp. 2056–2063, 2001. View at Publisher · View at Google Scholar
  41. E. M. M. D. B. Costa, M. Z. Fernandes, L. B. Quinder, L. B. de Souza, and L. P. Pinto, “Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia,” Pesquisa Odontologica Brasileira, vol. 17, no. 2, pp. 147–150, 2003. View at Google Scholar · View at Scopus
  42. ASPEN Board of Directors and the Clinical Guidelines Task Force, “Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients,” Journal of Parenteral and Enteral Nutrition, vol. 26, no. 1, supplement, pp. 1SA–138SA, 2002. View at Publisher · View at Google Scholar
  43. K. K. F. Cheng and A. M. Chang, “Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy,” Cancer Nursing, vol. 26, no. 6, pp. 476–484, 2003. View at Google Scholar · View at Scopus
  44. Y. Aisa, T. Mori, M. Kudo et al., “Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients,” Supportive Care in Cancer, vol. 13, no. 4, pp. 266–269, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. D. J. Mahood, A. M. Dose, C. L. Loprinzi et al., “Inhibition of fluorouracil-induced stomatitis by oral cryotherapy,” Journal of Clinical Oncology, vol. 9, no. 3, pp. 449–452, 1991. View at Google Scholar · View at Scopus
  46. I. von Bültzingslöwen, M. T. Brennan, F. K. L. Spijkervet et al., “Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis,” Supportive Care in Cancer, vol. 14, no. 6, pp. 519–527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. R. V. Lalla, “Velafermin CuraGen,” Current Opinion in Investigational Drugs, vol. 6, no. 11, pp. 1179–1185, 2005. View at Google Scholar · View at Scopus
  48. J. B. Epstein, S. Silverman Jr., D. A. Paggiarino et al., “Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial,” Cancer, vol. 92, no. 4, pp. 875–885, 2001. View at Publisher · View at Google Scholar
  49. RxKinetix Completes Its End of Phase 2 Meeting with the FDA for RK-0202 in Oral MucositIs and Is Now Moving into Phase 3, RxKinetix, Inc., Boulder, Colo, USA, 2006.
  50. B. Storey, “The role of oral glutamine in pediatric bone marrow transplant,” Journal of Pediatric Oncology Nursing, vol. 24, no. 1, pp. 41–45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. K. M. Skubitz and P. M. Anderson, “Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study,” Journal of Laboratory and Clinical Medicine, vol. 127, no. 2, pp. 223–228, 1996. View at Google Scholar · View at Scopus
  52. Lexi-Comp Online, Pediatric Lexi-Drugs online, Lexi-Comp, Inc., Hudson, Ohio, USA, 2011.
  53. J. L. Shenep, D. K. Kalwinsky, P. R. Hutson et al., “Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis,” Journal of Pediatrics, vol. 113, no. 4, pp. 758–763, 1988. View at Google Scholar · View at Scopus
  54. S. Vadhan-Raj, J. Trent, S. Patel et al., “Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial,” Annals of Internal Medicine, vol. 153, no. 6, pp. 358–367, 2010. View at Google Scholar · View at Scopus
  55. G. E. Djavid, “Low level laser therapy in management of chemotherapy-induced oral mucositis: prophylaxis or treatment?” Journal of Lasers in Medical Sciences, vol. 2, no. 1, 2011. View at Google Scholar
  56. J. E. Clarkson, H. V. Worthington, and O. B. Eden, “Interventions for treating oral candidiasis for patients with cancer receiving treatment,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001972, 2004. View at Google Scholar · View at Scopus
  57. D. M. Keefe, M. M. Schubert, L. S. Elting et al., “Updated clinical practice guidelines for the prevention and treatment of mucositis,” Cancer, vol. 109, no. 5, pp. 820–831, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Colella, R. Cannavale, A. Vicidomini, G. Rinaldi, D. Compilato, and G. Campisi, “Efficacy of a spray compound containing a pool of collagen precursor synthetic aminoacids (L-proline, L-leucine, L-lysine and glycine) combined with sodium hyaluronate to manage chemo/radiotherapy-induced oral mucositis: preliminary data of an open clinical trial,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 1, pp. 143–151, 2010. View at Google Scholar · View at Scopus
  59. I. L. Shannon, E. N. Starcke, and W. B. Wescott, “Effect of radiotherapy on whole saliva flow,” Journal of Dental Research, vol. 56, no. 6, pp. 693–694, 1977. View at Google Scholar · View at Scopus
  60. S. Dreizen, L. R. Brown, S. Handler, and B. M. Levy, “Radiation induced xerostomia in cancer patients. Effect on salivary and serum electrolytes,” Cancer, vol. 38, no. 1, pp. 273–278, 1976. View at Google Scholar · View at Scopus
  61. H. J. Keene and T. J. Fleming, “Prevalence of caries-associated microflora after radiotherapy in patients with cancer of the head and neck,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 64, no. 4, pp. 421–426, 1987. View at Google Scholar · View at Scopus
  62. M. Nasman, O. Bjork, S. Soderhall, O. Ringden, and G. Dahllof, “Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy,” Pediatric Dentistry, vol. 16, no. 3, pp. 217–223, 1994. View at Google Scholar
  63. K. W. Stephen, “Dentifrices: recent clinical findings and implications for use,” International Dental Journal, vol. 43, no. 6, pp. 549–553, 1993. View at Google Scholar · View at Scopus
  64. B. Sheller and B. Williams, “Orthodontic management of patients with hematologic malignancies,” The American Journal of Orthodontics and Dentofacial Orthopedics, vol. 109, no. 6, pp. 575–580, 1996. View at Google Scholar · View at Scopus
  65. E. Barbería, C. Hernandez, V. Miralles, and M. Maroto, “Paediatric patients receiving oncology therapy: review of the literature and oral management guidelines,” European Journal of Paediatric Dentistry, vol. 9, no. 4, pp. 188–194, 2008. View at Google Scholar · View at Scopus
  66. G. Alpaslan, C. Alpaslan, H. Gögen, A. Oguz, S. Çetiner, and C. Karadeniz, “Disturbances in oral and dental structures in patients with pediatric lymphoma after chemotherapy A preliminary report,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 87, no. 3, pp. 317–321, 1999. View at Google Scholar · View at Scopus
  67. National Cancer Institute, Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ) [Online], 2006.
  68. D. Antonadou, M. Pepelassi, M. Synodinou, M. Puglisi, and N. Throuvalas, “Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer,” International Journal of Radiation Oncology Biology Physics, vol. 52, no. 3, pp. 739–747, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. K. V. Rankin, D. L. Jones, and S. W. Redding, Oral Health in Cancer Therapy Conference: A Guide for Health Professionals, Texas Dental Oncology Education Program, Dallas, Tex, USA, 2nd edition, 2003.
  70. A. L. Sonis, N. Tarbell, R. W. Valachovic, R. Gelber, M. Schwenn, and S. Sallan, “Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities,” Cancer, vol. 66, pp. 2645–2652, 1990. View at Publisher · View at Google Scholar
  71. B. Guyuron, A. P. Dagys, I. R. Munro, and R. B. Ross, “Effect of irradiation on facial growth: a 7- to 25-year follow-up,” Annals of Plastic Surgery, vol. 11, no. 5, pp. 423–427, 1983. View at Google Scholar · View at Scopus
  72. J. Blatt, B. B. Bercu, J. C. Gillin, W. B. Mendelson, and D. G. Poplack, “Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia,” Journal of Pediatrics, vol. 104, no. 2, pp. 182–186, 1984. View at Publisher · View at Google Scholar
  73. S. M. Shalet, D. A. Price, C. G. Beardwell, P. H. Jones, and D. Pearson, “Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia,” Journal of Pediatrics, vol. 94, no. 5, pp. 719–722, 1979. View at Google Scholar · View at Scopus
  74. N. A. Samaan, R. Vieto, P. N. Schultz et al., “Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck,” International Journal of Radiation Oncology Biology Physics, vol. 8, no. 11, pp. 1857–1867, 1982. View at Google Scholar · View at Scopus